August Newsletter

This month we preview another big primary care conference that we're excited to be a part of. We also feature a great, recently launched podcast called Bloomly, where its founder Tegan Scates chats to Associate Professor Mike Armour about medicinal cannabis and its role in treating endometriosis, while our much-travelled CEO, Carmen Doran, is part of a great discussion on BNZ Connect. We're in hot demand from the country's politicians at the moment - we recap the Minister of Economic Development, Melissa Lee's, recent visit. There's also a chance for you to have your say on the 2degrees Auckland Business People's Choice Awards, where Helius is a finalist.

GPCME South

Hot on the heels of GPCME North in Rotorua, New Zealand’s primary care community will gather again from today until August 18th at GPCME South in Christchurch.

Helius will be there again answering the many questions we get about our medicinal cannabis products.

If you’re attending GPCME South, please come see us at Stand 913!

Bloomly podcast

If you haven’t yet come across the recently launched Bloomly podcast and its founder, Tegan Scates then here’s your chance to get acquainted.

This fantastic inaugural episode is a conversation between Tegan and highly regarded Associate Professor Mike Armour from the NICM Health Research Institute, Western Sydney University, where they delve into the intersection of endometriosis and medicinal cannabis. As Tegan explains:?

“With his extensive background in endometriosis, menstrual health, and complementary medicine, Mike provides an overview of the current landscape of research in women's health and medicinal cannabis. The episode covers significant research findings and reveals the therapeutic applications of medicinal cannabis for pain management in endometriosis.”?

It's a great listen, check it out here.

BNZ Connect

This insightful BNZ Connect discussion dovetails nicely with the regulatory changes announced last month, effectively lowering barriers to export. Hosted by Business Desk Investments Editor, Frances Cook, Helius CEO Carmen Doran and New Zealand Story Group CEO, David Downs , share invaluable advice about becoming export ready.

“Customers like doing business with New Zealand because we care for people, we care for place, and that - when you're talking about a plant-based medicine - is so critical in terms of that value base.”

Check out the full video here.?

Minister for Economic Development, Melissa Lee, visits Helius.

“Delivering results for our patients and society as a whole” has always been a core value at Helius.

Having Minister for Economic Development, Melissa Lee, visit a couple of weeks ago gave us the opportunity to discuss the implications of export regulatory changes that will allow us to help more patients in more countries, alongside our fellow Kiwis.?

Pictured L-R: NZTE Investment Manager, Don Stanway, NZTE Customer Manager, Terry Teoh, Carmen Doran , Minister for Economic Development, Melissa Lee and Helius Chief Quality Officer, Bruce Wallace.

Helius Therapeutics – the People’s Choice?

In this year’s 2degrees Auckland Business Awards, Helius Therapeutics is included in the People’s Choice Award. This award celebrates businesses that are truly making a difference. Unlike the other categories where a panel of learned judges makes the call, the People’s Choice Awards is 100% in the hands of the public via online voting.

Helius exists to unlock the extraordinary therapeutic potential of cannabis to improve quality of life. We have a bold vision – to become a world leader in the research, development and distribution of next-generation cannabinoid medicines. So if you think Helius has made a positive difference to you, your community and to its staff and stakeholders, you can vote for us here!

Share your story

If you have any questions or comments, your feedback is always welcome.

Contact: [email protected]